These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28847527)

  • 1. The safety and pharmacokinetics of high dose intravenous ascorbic acid synergy with modulated electrohyperthermia in Chinese patients with stage III-IV non-small cell lung cancer.
    Ou J; Zhu X; Lu Y; Zhao C; Zhang H; Wang X; Gui X; Wang J; Zhang X; Zhang T; Pang CLK
    Eur J Pharm Sci; 2017 Nov; 109():412-418. PubMed ID: 28847527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia.
    Tarng DC; Wei YH; Huang TP; Kuo BI; Yang WC
    Kidney Int; 1999 Jun; 55(6):2477-86. PubMed ID: 10354297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer.
    Ou J; Zhu X; Chen P; Du Y; Lu Y; Peng X; Bao S; Wang J; Zhang X; Zhang T; Pang CLK
    J Adv Res; 2020 Jul; 24():175-182. PubMed ID: 32368355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intravenous ascorbic acid on erythropoiesis and quality of life in unselected hemodialysis patients.
    Taji Y; Morimoto T; Okada K; Fukuhara S; Fukui T; Kuwahara T
    J Nephrol; 2004; 17(4):537-43. PubMed ID: 15372416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer.
    Bazzan AJ; Zabrecky G; Wintering N; Newberg AB; Monti DA
    Integr Cancer Ther; 2018 Sep; 17(3):912-920. PubMed ID: 29771164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic analysis of stage III-IV non-small cell lung cancer patients treated by traditional chinese medicine].
    Zhou DH; Lin LZ; Zhou YQ; Luo RC; Liu KF; Jia YJ; Chen JY; Niu XW; Su BR; Lu J; Wang ST
    Ai Zheng; 2005 Oct; 24(10):1252-6. PubMed ID: 16219143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Modulated Electrohyperthermia on the Pharmacokinetics of Oral Transmucosal Fentanyl Citrate in Healthy Volunteers.
    Lee SY; Kim MG
    Clin Ther; 2016 Dec; 38(12):2548-2554. PubMed ID: 27866658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer.
    DeVore RF; Johnson DH; Crawford J; Garst J; Dimery IW; Eckardt J; Eckhardt SG; Elfring GL; Schaaf LJ; Hanover CK; Miller LL
    J Clin Oncol; 1999 Sep; 17(9):2710-20. PubMed ID: 10561345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DHA-paclitaxel (Taxoprexin) as first-line treatment in patients with stage IIIB or IV non-small cell lung cancer: report of a phase II open-label multicenter trial.
    Payne M; Ellis P; Dunlop D; Ranson M; Danson S; Schacter L; Talbot D
    J Thorac Oncol; 2006 Nov; 1(9):984-90. PubMed ID: 17409983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the effects of mEHT on the treatment-related toxicity and quality of life of HIV-positive cervical cancer patients.
    Minnaar CA; Kotzen JA; Naidoo T; Tunmer M; Sharma V; Vangu MD; Baeyens A
    Int J Hyperthermia; 2020; 37(1):263-272. PubMed ID: 32180481
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxidant stress and B vitamins status in patients with non-small cell lung cancer.
    Tsao SM; Yin MC; Liu WH
    Nutr Cancer; 2007; 59(1):8-13. PubMed ID: 17927496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of ascorbic acid after high-dose infusion in prostate cancer patients: a pharmacokinetic evaluation.
    Nielsen TK; Højgaard M; Andersen JT; Poulsen HE; Lykkesfeldt J; Mikines KJ
    Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):343-8. PubMed ID: 25220574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief Report: Stability and Chemical Characteristics of Injectable Ascorbic Acid for Patients With Cancer.
    Monti DA; Bazzan AJ; Zabrecky G; Newberg AB
    Altern Ther Health Med; 2019 Mar; 25(2):42-45. PubMed ID: 28987078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer.
    Yasuda H; Yamaya M; Nakayama K; Sasaki T; Ebihara S; Kanda A; Asada M; Inoue D; Suzuki T; Okazaki T; Takahashi H; Yoshida M; Kaneta T; Ishizawa K; Yamanda S; Tomita N; Yamasaki M; Kikuchi A; Kubo H; Sasaki H
    J Clin Oncol; 2006 Feb; 24(4):688-94. PubMed ID: 16446342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer.
    Stephenson CM; Levin RD; Spector T; Lis CG
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):139-46. PubMed ID: 23670640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients.
    Fiorentini G; Sarti D; Casadei V; Milandri C; Dentico P; Mambrini A; Nani R; Fiorentini C; Guadagni S
    Integr Cancer Ther; 2019; 18():1534735419878505. PubMed ID: 31561722
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential enhancement of host immunity and anti-tumor efficacy of nanoscale curcumin and resveratrol in colorectal cancers by modulated electro- hyperthermia.
    Kuo IM; Lee JJ; Wang YS; Chiang HC; Huang CC; Hsieh PJ; Han W; Ke CH; Liao ATC; Lin CS
    BMC Cancer; 2020 Jun; 20(1):603. PubMed ID: 32600429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
    Herbst RS; Hammond LA; Carbone DP; Tran HT; Holroyd KJ; Desai A; Williams JI; Bekele BN; Hait H; Allgood V; Solomon S; Schiller JH
    Clin Cancer Res; 2003 Sep; 9(11):4108-15. PubMed ID: 14519633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial.
    Lau D; Leigh B; Gandara D; Edelman M; Morgan R; Israel V; Lara P; Wilder R; Ryu J; Doroshow J
    J Clin Oncol; 2001 Jan; 19(2):442-7. PubMed ID: 11208837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Putative Abscopal Effect in Three Patients Treated by Combined Radiotherapy and Modulated Electrohyperthermia.
    Chi MS; Mehta MP; Yang KL; Lai HC; Lin YC; Ko HL; Wang YS; Liao KW; Chi KH
    Front Oncol; 2020; 10():254. PubMed ID: 32211319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.